Key result
Patients with hypertrophic cardiomyopathy most frequently reported shortness of breath, tiredness, and dizziness (each 89%), which led to significant limitations in physical activities and emotional well-being.
Why the study?
There is a general lack of knowledge regarding patients' perspectives on the symptoms and daily limitations experienced from hypertrophic cardiomyopathy.
Observational (n=471)
Yes
A conceptual model of HCM patient experiences identifies shortness of breath, palpitations, fatigue, dizziness, and chest pain as core symptoms, informing the development of patient-reported outcome instruments.
Patient experiences in oHCM and nHCM remain incompletely mapped; leaves open standardized incorporation into care and trials.
Background Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder defined by left ventricular hypertrophy that cannot be explained by another cardiac or systemic disease. There is a general lack of knowledge about patients’ perspectives on the symptoms and day-to-day limitations they experience as a result of HCM. We therefore sought an in-depth understanding of patients’ experiences of obstructive (oHCM) and nonobstructive (nHCM) forms of the disease, including symptoms and their quality of life impacts, and to develop a conceptual model to capture them. Methods Development of the HCM conceptual model involved a web-based survey to capture patients’ insights, a targeted literature review (which included relevant guidelines and patient advocacy websites), one-to-one interviews with clinical experts, and one-to-one qualitative concept elicitation interviews with patients. Key symptoms and their impacts most important to patients’ experiences were identified and used to develop a conceptual model of the patient experience with HCM. Results The HCM symptoms reported by patient interviewees (n = 27) were largely consistent with findings from the patient web survey (n = 444), literature review, and interviews with three expert clinicians. The symptoms most commonly reported in patient interviews included tiredness (89%), shortness of breath (89%), shortness of breath with physical activity (89%), and dizziness/light-headedness (89%). Other symptoms commonly reported included chest pain (angina) (70%), chest pain (angina) with physical exertion (70%), and palpitations (fluttering or rapid heartbeat) (81%). The most commonly reported impacts of HCM symptoms on patients’ lives included limitations to physical activities (78%), emotional impacts, including feeling anxious or depressed (78%), and impacts on work (63%). Symptoms and impacts were similar for both oHCM and nHCM. Conclusions A conceptual model was developed, which identifies the core symptoms that patients with oHCM and nHCM reported as most frequent and most important: shortness of breath, palpitations, fatigue/tiredness, dizziness/light-headedness, and chest pain, as well as the impacts those symptoms have on patients’ lives. This HCM conceptual model reflecting patients’ experiences and perspectives was used in the development of a patient-reported outcomes instrument for use in clinical trials and it may also help inform the clinical management of HCM.
No takes yet. Share an insight, caveat, or question.
Zaiser et al. (2020) conducted an observational in Hypertrophic cardiomyopathy (n=471). Hypertrophic cardiomyopathy (obstructive and nonobstructive) was evaluated on Frequency of reported HCM symptoms and impacts on quality of life. Patients with hypertrophic cardiomyopathy most frequently reported shortness of breath, tiredness, and dizziness (each 89%), which led to significant limitations in physical activities and emotional well-being.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: